Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Arrowhead Pharmaceuticals Corp (ARWR) Climbs 25% After Shares Resume Trading
October 4, 2018 7:51 AM EDTArrowhead Pharmaceuticals Corp (NASDAQ: ARWR) Climbs 25% After Shares Resume Trading
... MoreArrowhead Pharmaceuticals Corp (ARWR) to Resume Trading at 7:50 am ET
October 4, 2018 7:33 AM EDTArrowhead Pharmaceuticals Corp (NASDAQ: ARWR) to Resume Trading at 7:50 am ET
... More
